<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7808616</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7840</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Neurosci.</journal-id>
<journal-title-group>
<journal-title>Trends in neurosciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0166-2236</issn>
<issn pub-type="epub">1878-108X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30563709</article-id>
<article-id pub-id-type="pmc">6382467</article-id>
<article-id pub-id-type="doi">10.1016/j.tins.2018.11.002</article-id>
<article-id pub-id-type="manuscript">NIHMS1512957</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of <italic>de novo</italic> noncoding regulatory mutations
in neurodevelopmental disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Turner</surname>
<given-names>Tychele N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichler</surname>
<given-names>Evan E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1)</label>Department of Genome Sciences, University of Washington
School of Medicine, Seattle, WA, USA</aff>
<aff id="A2"><label>2)</label>Howard Hughes Medical Institute, University of Washington,
Seattle, WA, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author: Evan E. Eichler, Ph.D.,
University of Washington School of Medicine, Howard Hughes Medical Institute,
3720 15th Ave NE, S413C, Box 355065, Seattle, WA 98195-5065,Phone: (206)
543-9526, <email>eee@gs.washington.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P22">CONFLICT OF INTEREST DISCLOSURE</p>
<p id="P23">E.E.E. is on the scientific advisory board (SAB) of DNAnexus, Inc.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>42</volume>
<issue>2</issue>
<fpage>115</fpage>
<lpage>127</lpage>
<!--elocation-id from pubmed: 10.1016/j.tins.2018.11.002-->
<abstract id="ABS1">
<p id="P1">Advances in sequencing technology have significantly expanded our
understanding of the genetics of autism and neurodevelopmental disorders (NDDs).
Continued technological improvements and cost reductions have now shifted the
focus to investigations into the functional noncoding portions of the genome.
There is a patient trend toward an excess of <italic>de novo</italic> and
potentially disruptive mutation among conserved noncoding sequences implicated
in the regulation of genes. The signals become stronger when restricting to
genes already implicated in NDDs, but <italic>de novo</italic> mutation in such
elements is estimated to account for &lt;5% of patients. Larger sample
sizes, improved variant detection, functional testing, and better approaches for
classifying noncoding variation will be required to identify specific pathogenic
variants underlying disease.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>noncoding</kwd>
<kwd>regulatory mutations</kwd>
<kwd>genome sequencing</kwd>
<kwd>genetic architecture</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>